Numenos AI

Numenos AI is a company operating in the New York artificial intelligence scene[1]. Founded in 2023[2], the company operates in the biotechnology research industry[3]. Numenos was established on the premise that biology lacks the foundational laws that make physics predictive, and that tools to discover such laws are currently unavailable[2]. According to the company's stated perspective, medicine today treats diseases as separate, isolated problems, with cancer researchers, autoimmune specialists, and neurologists each operating in distinct silos and learning correlations specific to their respective diseases without discovering deeper connecting principles[2]. The company has 19 employees[3].

Something wrong or missing? Send a correction. Fixed within 24 hours.